Search for other papers by Maria Mizamtsidi in
Google Scholar
PubMed
Search for other papers by Constantinos Nastos in
Google Scholar
PubMed
Search for other papers by George Mastorakos in
Google Scholar
PubMed
Search for other papers by Roberto Dina in
Google Scholar
PubMed
Search for other papers by Ioannis Vassiliou in
Google Scholar
PubMed
Search for other papers by Maria Gazouli in
Google Scholar
PubMed
Search for other papers by Fausto Palazzo in
Google Scholar
PubMed
proliferation of parenchymal cells, with little or no extracellular fat or nodular development consisting mainly by chief cells, although foci of oncocytes and clear cells may be admixed ( 37 ). There are two major types of histological hyperplastic
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Garvan Institute of Medical Research, New South Wales, Australia
School of Medical Sciences, University of New South Wales, New South Wales, Australia
Search for other papers by Vita Birzniece in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Department of Diabetes and Endocrinology, Westmead Hospital, New South Wales, Australia
Search for other papers by Teresa Lam in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Search for other papers by Mark McLean in
Google Scholar
PubMed
Search for other papers by Navneeta Reddy in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Search for other papers by Haleh Shahidipour in
Google Scholar
PubMed
Faculty of Medicine, Health and Human Sciences, Macquarie University, New South Wales, Australia
Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia
Search for other papers by Amy Hayden in
Google Scholar
PubMed
Search for other papers by Howard Gurney in
Google Scholar
PubMed
Search for other papers by Glenn Stone in
Google Scholar
PubMed
Endocrine Research Unit, Department of Endocrinology, Odense University Hospital & Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark
Steno Diabetes Center Odense, Odense University Hospital & Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark
Search for other papers by Rikke Hjortebjerg in
Google Scholar
PubMed
Endocrine Research Unit, Department of Endocrinology, Odense University Hospital & Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark
Search for other papers by Jan Frystyk in
Google Scholar
PubMed
pathway ( 13 , 14 , 15 , 16 ). There is increasing evidence that metformin, by modulating insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs), may inhibit cancer proliferation and spread. Recent studies show that metformin inhibits
Search for other papers by Lin Ji in
Google Scholar
PubMed
Search for other papers by Huan-Tong Wu in
Google Scholar
PubMed
Search for other papers by Xiao-Yan Qin in
Google Scholar
PubMed
Search for other papers by Rongfeng Lan in
Google Scholar
PubMed
, decreased intestinal barrier function NPY Bar et al . 2014 Cancer – CPE induces cell survival and proliferation; ΔN-CPE promotes tumor growth and metastasis – Horing et al . 2012 , Lee et al . 2011 Gastrointestinal deficits Cpe
Search for other papers by Juan Carlos Juárez-Cruz in
Google Scholar
PubMed
Search for other papers by Miriam Daniela Zuñiga-Eulogio in
Google Scholar
PubMed
Search for other papers by Monserrat Olea-Flores in
Google Scholar
PubMed
Search for other papers by Eduardo Castañeda-Saucedo in
Google Scholar
PubMed
Search for other papers by Miguel Ángel Mendoza-Catalán in
Google Scholar
PubMed
Search for other papers by Carlos Ortuño-Pineda in
Google Scholar
PubMed
Search for other papers by Ma Elena Moreno-Godínez in
Google Scholar
PubMed
Search for other papers by Sócrates Villegas-Comonfort in
Google Scholar
PubMed
Search for other papers by Teresita Padilla-Benavides in
Google Scholar
PubMed
Search for other papers by Napoleón Navarro-Tito in
Google Scholar
PubMed
levels of estrogens, which in turn reduce gonadotrophin release, and decreased progesterone levels, thus reducing cell proliferation in mammary glands ( 14 ). Contradictory studies in this regard have proposed that progesterone may be protective against
Search for other papers by Antonia Ertelt in
Google Scholar
PubMed
Search for other papers by Ann-Kristin Barton in
Google Scholar
PubMed
Search for other papers by Robert R Schmitz in
Google Scholar
PubMed
Search for other papers by Heidrun Gehlen in
Google Scholar
PubMed
not only by hypertrophic expansion of adipocytes, but also by a proliferation process which increases the number of adipocytes (10) . There are two different types of adipocytes within white adipose tissue: normal ‘white’ fat cells and ‘brite’ brown
Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI-CONICET), Haya de la Torre y Medina Allende, Ciudad Universitaria, Córdoba (X5000HUA), Argentina
Search for other papers by Rocío del Carmen Bravo-Miana in
Google Scholar
PubMed
Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI-CONICET), Haya de la Torre y Medina Allende, Ciudad Universitaria, Córdoba (X5000HUA), Argentina
Search for other papers by Ana Belén Della Vedova in
Google Scholar
PubMed
Instituto de Investigaciones en Ciencias de la Salud (INICSA-CONICET), Av. Enrique Barros y Enfermera Gordillo, Ciudad Universitaria, Córdoba, Argentina
Search for other papers by Ana Lucía De Paul in
Google Scholar
PubMed
Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI-CONICET), Haya de la Torre y Medina Allende, Ciudad Universitaria, Córdoba (X5000HUA), Argentina
Search for other papers by María Mónica Remedi in
Google Scholar
PubMed
Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI-CONICET), Haya de la Torre y Medina Allende, Ciudad Universitaria, Córdoba (X5000HUA), Argentina
Search for other papers by María Laura Guantay in
Google Scholar
PubMed
Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI-CONICET), Haya de la Torre y Medina Allende, Ciudad Universitaria, Córdoba (X5000HUA), Argentina
Search for other papers by Mónica Beatriz Gilardoni in
Google Scholar
PubMed
Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI-CONICET), Haya de la Torre y Medina Allende, Ciudad Universitaria, Córdoba (X5000HUA), Argentina
Search for other papers by Claudia Gabriela Pellizas in
Google Scholar
PubMed
Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI-CONICET), Haya de la Torre y Medina Allende, Ciudad Universitaria, Córdoba (X5000HUA), Argentina
Search for other papers by Ana Carolina Donadio in
Google Scholar
PubMed
to alter the phenotype of recipient cells, transform benign cells and depress the immune response, induce epithelial-mesenchymal transition and support endothelial proliferation and blood vessel sprouting ( 13 , 14 ). Interestingly, CD147 has been
Search for other papers by June Young Choi in
Google Scholar
PubMed
Search for other papers by Jin Wook Yi in
Google Scholar
PubMed
Search for other papers by Jun Hyup Lee in
Google Scholar
PubMed
Search for other papers by Ra-Yeong Song in
Google Scholar
PubMed
Search for other papers by Hyeongwon Yu in
Google Scholar
PubMed
Search for other papers by Hyungju Kwon in
Google Scholar
PubMed
Search for other papers by Young Jun Chai in
Google Scholar
PubMed
Search for other papers by Su-jin Kim in
Google Scholar
PubMed
Search for other papers by Kyu Eun Lee in
Google Scholar
PubMed
antitumor activities of 1,25D include the inhibition of cancer cell proliferation and angiogenesis, promotion of cell differentiation and apoptosis ( 4 , 5 , 6 , 7 , 8 ). The VDR is a receptor expressed by epithelial cells in both normal and
Search for other papers by Xiaomin Li in
Google Scholar
PubMed
Search for other papers by Ling Fang in
Google Scholar
PubMed
Search for other papers by Hongjiang Li in
Google Scholar
PubMed
Search for other papers by Xiaoqin Yang in
Google Scholar
PubMed
estrogen receptor (ER), estrogen can activate the receptor signaling pathways to promote cell growth, proliferation, and endometrial hyperplasia, ultimately leading to the occurrence of cancer ( 8 , 9 , 10 ). Estrogen metabolites cause noticeably
Search for other papers by Simonetta Piana in
Google Scholar
PubMed
Search for other papers by Eleonora Zanetti in
Google Scholar
PubMed
Search for other papers by Alessandra Bisagni in
Google Scholar
PubMed
Search for other papers by Alessia Ciarrocchi in
Google Scholar
PubMed
Search for other papers by Davide Giordano in
Google Scholar
PubMed
Search for other papers by Federica Torricelli in
Google Scholar
PubMed
Search for other papers by Teresa Rossi in
Google Scholar
PubMed
Search for other papers by Moira Ragazzi in
Google Scholar
PubMed
explore whether high NOTCH1 expression could reflect higher proliferation rate of these tumors, we explored Ki67 expression in the 48 PTCs included in this analysis. In all samples, Ki67 positivity was limited (below 10% of cancer cells) independently to
Search for other papers by Anna-Pauliina Iivonen in
Google Scholar
PubMed
Search for other papers by Johanna Känsäkoski in
Google Scholar
PubMed
Search for other papers by Atte Karppinen in
Google Scholar
PubMed
Search for other papers by Leena Kivipelto in
Google Scholar
PubMed
Search for other papers by Camilla Schalin-Jäntti in
Google Scholar
PubMed
Search for other papers by Auli Karhu in
Google Scholar
PubMed
Search for other papers by Taneli Raivio in
Google Scholar
PubMed
, which was associated with proliferation of colorectal cancer cells and epithelial-to-mesenchymal transition (EMT) ( 23 ). KCNQ1 is present in the somatotrope cell membrane ( 9 ), and E-cadherin is expressed in somatotropinomas ( 25 ). In a study by